• LAST PRICE
    20.1800
  • TODAY'S CHANGE (%)
    Trending Down-0.0500 (-0.2472%)
  • Bid / Lots
    20.0100/ 1
  • Ask / Lots
    20.4500/ 1
  • Open / Previous Close
    20.2400 / 20.2300
  • Day Range
    Low 20.1500
    High 20.3000
  • 52 Week Range
    Low 7.3400
    High 32.2700
  • Volume
    115,240
    above average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Monday's close: 20.23
TimeVolumeOPNT
09:32 ET173720.275
09:33 ET10020.275
09:35 ET30020.28
09:42 ET50020.2523
09:48 ET52520.27
10:00 ET696920.24
10:02 ET2087420.2
10:04 ET323720.25
10:08 ET139920.23
10:09 ET500020.24
10:26 ET10020.22
10:27 ET249920.28
10:36 ET217020.275
10:45 ET20020.27
10:47 ET170020.26
10:51 ET10020.26
11:00 ET10020.26
11:02 ET20020.26
11:05 ET25020.2522
11:07 ET290320.265
11:09 ET90620.18
11:21 ET929620.185
11:48 ET221320.2275
12:10 ET196720.2
12:28 ET20020.19
12:55 ET10020.2075
01:22 ET10020.19
01:24 ET96020.21
01:51 ET262220.185
01:54 ET50020.2
01:58 ET45020.19
02:14 ET85920.1906
02:32 ET10020.21
02:38 ET10020.21
02:39 ET70020.19
02:57 ET20020.19
02:59 ET30020.19
03:06 ET1049820.18
03:08 ET10020.17
03:10 ET10020.17
03:12 ET10020.17
03:17 ET40020.16
03:19 ET21320.1525
03:21 ET71720.15
03:26 ET55020.15
03:28 ET20020.15
03:30 ET10020.155
03:32 ET161120.15
03:33 ET378020.155
03:35 ET10020.15
03:37 ET80020.16
03:39 ET12020.155
03:42 ET60020.16
03:44 ET182120.16
03:46 ET73520.17
03:48 ET115820.23
03:51 ET10020.23
03:53 ET10020.23
03:55 ET20020.21
03:57 ET540020.18
04:00 ET167820.18
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesOPNT
Opiant Pharmaceuticals Inc
106.6M
-3.1x
---
United StatesCDTX
Cidara Therapeutics Inc
86.7M
-2.3x
---
United StatesCSBR
Champions Oncology Inc
56.3M
1,022.4x
---
United StatesXERS
Xeris Biopharma Holdings Inc
165.9M
-1.2x
---
United StatesPIRS
Pieris Pharmaceuticals Inc
118.3M
-3.4x
---
United StatesFIXX
Homology Medicines Inc
82.8M
-17.2x
---
As of 2023-01-31

Company Information

Opiant Pharmaceuticals, Inc., is a specialty pharmaceutical company developing medicines for addictions and drug overdose. The Company has developed NARCAN (naloxone hydrochloride) Nasal Spray, a treatment to reverse opioid overdose. Its lead development product include OPNT003. The Company’s pipeline includes medicines in development for Opioid Overdose Reversal (OOR), Alcohol Use Disorder (AUD), Opioid Use Disorder (OUD), and Acute Cannabinoid Overdose (ACO). The Company also is focused on other treatment opportunities within the addiction and drug overdose field.

Contact Information

Headquarters
233 Wilshire Blvd, Suite 400SANTA MONICA, CA, United States 90401
Phone
310-598-5410
Fax
302-636-5454

Executives

Chief Executive Officer, Director
Roger Crystal
Chief Financial Officer
David O'Toole
Chief Scientific Officer
Phil Skolnick
Independent Director
Craig Collard
Independent Director
Richard Daly

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$106.6M
Revenue (TTM)
$22.3M
Shares Outstanding
5.3M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
0.83
EPS
$-6.56
Book Value
$9.54
P/E Ratio
-3.1x
Price/Sales (TTM)
4.8
Price/Cash Flow (TTM)
---
Operating Margin
-141.05%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.